COVID-19 mRNA Vaccine and Myocarditis

  • Balraj Singh Department of Hematology-Oncology, Saint Joseph's University Medical Center, Paterson, New Jerse https://orcid.org/0000-0001-7986-6031
  • Parminder Kaur Department of Cardiology, Saint Joseph's University Medical Center, Paterson, New Jersey https://orcid.org/0000-0002-7015-3489
  • Leon Cedeno Department of Internal Medicine, Saint Joseph's University Medical Center, Paterson, New Jersey
  • Taulant Brahimi Department of Internal Medicine, Saint Joseph's University Medical Center, Paterson, New Jersey
  • Prem Patel Department of Cardiology, Saint Joseph's University Medical Center, Paterson, New Jersey
  • Hartaj Virk Department of Cardiology, Saint Joseph's University Medical Center, Paterson, New Jersey
  • Fayez Shamoon Department of Cardiology, Saint Joseph's University Medical Center, Paterson, New Jersey
  • Manesh Bikkina Department of Cardiology, Saint Joseph's University Medical Center, Paterson, New Jersey
DOI: https://doi.org/10.12890/2021_002681

Keywords

COVID-19, severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, myocarditis, COVID-19 vaccine, side effects, adverse events, pericarditis, inflammation of the heart

Abstract

Coronavirus disease 2019 (COVID-19) is believed to have originated in the Hua nan South China Seafood Market in Wuhan and can present with a spectrum of clinical manifestations. We report the case of 24-year-old male patient who developed chest pain after administration of the second dose of the Pfizer-BioNTech mRNA COVID-19 vaccine and who was diagnosed with myocarditis on work-up.

VIEW THE ENTIRE ARTICLE

References

  • Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 2003;42(3):466–472.
  • Rose NR. Viral myocarditis. Curr Opin Rheumatol 2016;28(4):383–389.
  • Rezkalla SH, Kloner RA. Viral myocarditis: 1917-2020: from the influenza A to the COVID-19 pandemics. Trends Cardiovasc Med 2021;31(3):163–169.
  • Halsell JS, Riddle JR, Atwood JE, Gardner P, Shope R, Poland GA, et al. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA 2003;289(24):3283–3289.
  • Veronese G, Ammirati E, Cipriani M, Frigerio M. Fulminant myocarditis: characteristics, treatment, and outcomes. Anatol J Cardiol 2018;19(4):279–286.
  • Shimabukuro TT, Cole M, Su JR. Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US—December 14, 2020-January 18, 2021. JAMA 2021;325(11):1101–1102.
  • Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med 2021;384(22):2092–2101.
  • Centers for Disease Control and Prevention. Myocarditis and pericarditis following mRNA COVID-19 vaccination. 2021. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/myocarditis.html.
  • Vogel G, Couzin-Frankel J. Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men. Science 2021. Available from: https://www.sciencemag.org/news/2021/06/israel-reports-link-between-rare-cases-heart-inflammation-and-covid-19-vaccination

    • Published: 2021-06-14

    Issue: 2021: Vol 8 No 6 (view)

    Section: Articles

    How to cite:
    1.
    Singh B, Kaur P, Cedeno L, Brahimi T, Patel P, Virk H, Shamoon F, Bikkina M. COVID-19 mRNA Vaccine and Myocarditis. EJCRIM 2021;8 doi:10.12890/2021_002681.